Mesoblast Limited vs Vital Farms Inc — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Vital Farms Inc trades at $11.57 (market cap $496.50M). The key difference: Mesoblast Limited is far larger — about 4.5× Vital Farms Inc's market cap, and Mesoblast Limited is trading nearer its 52-week high, Vital Farms Inc nearer its low. Which is the better fit depends on your goals.
| MESO | VITL | |
|---|---|---|
Market Cap | $2.21B | $496.50M |
Sector | Technology | Consumer Staples |
52-Week High | $20.96 | $52.41 |
52-Week Low | $12.88 | $8.28 |
Enterprise Value | $2.21B | $583.51M |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →